Attitudes toward methadone among out-of-treatment minority injection drug users: Implications for health disparities

International Journal of Environmental Research and Public Health

Volumn 6, Issue 2, 2009, Pages 787-797

  Zaller, Nickolas D ^a,b   Bazazi, Alexander R ^a   Velazquez, Lavinia ^c   Rich, Josiah D ^a,b  

^a MIRIAM HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c MAP Behavioral Health Services (MAP Outreach Program)   (United States)

Author keywords

Health disparities; HIV AIDS; Injection drug use; Methadone

Indexed keywords

METHADONE;

ADULT; AFRICAN AMERICAN; ARTICLE; ATTITUDE TO HEALTH; CONSULTATION; DRUG ABUSE; DRUG COST; DRUG USE; ETHNIC GROUP; FEMALE; HEALTH BELIEF; HEALTH DISPARITY; HEALTH HAZARD; HISPANIC; HUMAN; KNOWLEDGE; MALE; PERCEPTION; RACE; TREATMENT WITHDRAWAL;

HEPATITIS C VIRUS;

EID: 61449268136     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6020787     Document Type: Article

References (41)

1. Brady, J.E.; Friedman, S.R.; Cooper, H.L.F.; Flom, P.L.; Tempalski, B.; Gostnell, K. Estimating the Prevalence of Injection Drug Users in the U.S. and in Large U.S. Metropolitan Areas from 1992 to 2002. J. Urban Health 2008, 85, 323-351.
2. Cooper, H.; Friedman, S.R.; Tempalski, B.; Friedman, R.; Keem, M. Racial/Ethnic Disparities in Injection Drug Use in Large US Metropolitan Areas. Ann. Epidemiol. 2005, 15, 326-334.
3. Cooper, H.L.F.; Brady, J.E.; Friedman, S.R.; Tempalski, B.; Gostnell, K.; Flom, P.L. Estimating the Prevalence of Injection Drug Use among Black and White Adults in Large U.S. Metropolitan Areas over Time (1992-2002): Estimation Methods and Prevalence Trends. J. Urban Health 2008, 85, 826-856.
4. Borrell, L. Racial Identity Among Hispanics: Implications for Health and Well-Being. Am. J. Public Health 2005, 95, 379-381.
5. Alvarez, J.; Olson, B.D.; Jason, L.A.; Davis, M.I.; Ferrari, J.R. Heterogeneity among Latinas and Latinos entering substance abuse treatment: Findings from a national database. J. Subst. Abuse Treat. 2004, 26, 277-284.
6. Warner, L.A.; Valdez, A.; Vega, W.A.; de la Rosa, M.; Turner, R.J.; Canino, G. Hispanic drug abuse in an evolving cultural context: an agenda for research. Drug Alcohol Dependence 2006, 84, S8-16.
7. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2006. Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA, USA, 2008; Vol. 18.
8. Cooper, H.L.; Friedman, S.R.; Tempalski, B.; Friedman, R. Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas. Am. J. Public Health 2007, 97, 344-52.
9. Tempalski, B.; Lieb, S.; Cleland, C.M.; Cooper, H.; Brady, J.E.; Friedman, S.R. HIV Prevalence Rates among Injection Drug Users in 96 Large US Metropolitan Areas, 1992-2002. J. Urban Health 2009, 86, 732-754.
10. Glaze, L.E.; Bonczar, T.P. Probation and Parole in the United States, 2007 Statistical Tables. Bureau Justice Statistics 2008. Available at http://www.ojp.usdoj.gov/bjs/abstract/ppus07st.htm (accessed February 1, 2009).
11. Amon, J.J.; Garfein, R.S.; Ahdieh-Grant, L.; Armstrong, G.L.; Ouellet, L.J.; Latka, M.H.; Vlahov, D.; Strathdee, S.A.; Hudson, S.M.; Kerndt, P.; Jarlais, D.D.; Williams, I.T. Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994-2004. Clin. Infect. Disease. 2008, 46, 1852-8.
12. Lelutiu-Weinberger, C.; Pouget, E.R.; Jarlais, D.D.C.D.; Cooper, H.L.; Scheinmann, R.; Stern, R.; Strauss, S.M.; Hagan, H. A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc. Sci. Med. 2008, 68, 579-590.
13. Kottiri, B.J.; Friedman, S.R.; Neaigus, A.; Curtis, R.; Jarlais, D.C.D. Risk Networks and Racial/Ethnic Differences in the Prevalence of HIV Infection Among Injection Drug Users. J. Acquir. Immune Defic. Syndr. 2002, 30, 95-104.
14. Estrada, A.L. Epidemiology of HIV/AIDS, Hepatitis B, Hepatitis C, and Tuberculosis Among Minority Injection Drug Users. Public Health Reports 2002, 117, S126-S134.
15. Galea, S.; Ahern, J.; Tardiff, K.; Leon, A.; Coffin, P.O.; Derr, K.; Vlahov, D. Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998. J. Urban Health 2003, 80, 201-11.
16. Marsh, J.C.; Cao, D.; Guerrero, E.; Shin, H.-C. Need-service matching in substance abuse treatment: Racial/ethnic differences. Eval. Program. Plann. 2009, 32, 43-51.
17. Wells, K.; Klap, R.; Koike, A.; Sherbourne, C. Ethnic Disparities in Unmet Need for Alcoholism, Drug Abuse, and Mental Health Care. Am. J. Psychiat 2001, 158, 2027-2032.
18. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Smedley, B.D., Stith, A.Y., Nelson, A.R., Eds.; The National Academies Press: Washington, DC, USA, 2003.
19. Wu, L.-T.; Kouzis, A.C.; Schlenger, W.E. Substance Use, Dependence, and Service Utilization Among the US Uninsured Nonelderly Population. Am. J. Public Health 2003, 93, 2079-2085.
20. Kleber, H.D. Methadone maintenance 4 decades later: thousands of lives saved but still controversial. JAMA 2008, 300, 2303-2305.
21. Joseph, H.; Stancliff, S.; Langrod, J. Methadone Maintenance Treatment (MMT): A Review of Historical and Clinical Issues. Mt. Sinai. J. Med. 2000, 67, 347-364.
22. Gottheil, E.; Sterling, R.; Weinstein, S. Diminished illicit drug use as a consequence of long-term methadone maintenance. JAMA 1993, 283, 1303-1310.
23. Mattick, R.; Breen, C.; Kimber, J.; Davoli, M.; Breen, R. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst. Rev. 2003, 2, DOI: 10.1002/14651858.CD002209.
24. Gowing, L.; Farrell, M.; Bornemann, R.; Sullivan, L.; Ali, R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst. Rev. 2008, 2, DOI: 10.1002/14651858.CD004145.pub3.
25. Metzger, D.; Woody, G.; McLellan, A.; O'Brien, C.; Druley, P.; Navaline, H.; DePhilippis, D.; Stolley, P.; Abrutyn, E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J. Acquir. Immune Defic. Syndr. 1993, 6, 1049-1056.
26. Clausen, T.; Anchersen, K.; Waal, H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008, 94, 151-157.
27. Langendam, M.; van Brussel, G.; Coutinho, R.; van Ameijden, E. The impact of harm-reduction- based methadone treatment on mortality among heroin users. Am. J. Public Health 2001, 91, 774-780.
28. Sheerin, I.; Green, T.; Sellman, D.; Adamson, S.; Deering, D. Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. N. Z. Med. J. 2004, 117, U795.
29. Marsch, L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998, 93, 515-532.
30. Stancliff, S.; Myers, J.E.; Steiner, S.; Drucker, E. Beliefs about methadone in an inner-city methadone clinic. J. Urban Health 2002, 79, 571-578.
31. Sees, K.L.; Delucchi, K.L.; Masson, C.; Rosen, A.; Clark, H.W.; Robillard, H.; Banys, P.; Hall, S.M. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 2000, 283, 1303-1310.
32. Masson, C.L.; Barnett, P.G.; Sees, K.L.; Delucchi, K.L.; Rosen, A.; Wong, W.; Hall, S.M. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180- day methadone detoxification. Addiction 2004, 99, 718-726.
33. Lundgren, L.M.; Amodeo, M.; Ferguson, F.; Davis, K. Racial and ethnic differences in drug treatment entry of injection drug users in Massachusetts. J. Subst. Abuse Treat. 2001, 21, 145-153.
34. Farabee, D.; Leukefeld, C.G.; Hays, L. Accessing Drug-Abuse Treatment: Perceptions of Out-of-treatment Injectors. J. Drug Issues 1998, 28, 381-394.
35. Peterson, J.A.; Schwartz, R.P.; Mitchell, S.G.; Reisinger, H.S.; Kelly, S.M.; O'Grady, K.E.; Brown, B.S.; Agar, M.H. Why don't out-of-treatment individuals enter methadone treatment programmes? Int. J. Drug Policy 2008.
36. Hunt, D.E.; Lipton, D.S.; Goldsmith, D.S.; Strug, D.L.; Spunt, B. "It takes your heart": the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int. J. Addiction. 1985, 20, 1751-1771.
37. Rosenblum, A.; Magura, S.; Joseph, H. Ambivalence toward methadone treatment among intravenous drug users. J. Psychoactive Drug. 1991, 23, 21-27.
38. Schwartz, R.P.; Kelly, S.M.; O'Grady, K.E.; Mitchell, S.G.; Peterson, J.A.; Reisinger, H.S.; Agar, M.H.; Brown, B.S. Attitudes Toward Buprenorphine and Methadone Among Opioid-Dependent Individuals. Am. J. Addict. 2008, 17, 396-401.
39. Porter, J. The Street/Treatment Barrier: Treatment Experiences of Puerto Rican Injection Drug Users. Sub. Use Misuse 1999, 34, 1951-1975.
40. Alegria, M.; Page, J.B.; Hansen, H.; Cauce, A.M.; Robles, R.; Blanco, C.; Cortes, D.E.; Amaro, H.; Morales, A.; Berry, P. Improving drug treatment services for Hispanics: research gaps and scientific opportunities. Drug Alcohol Depend. 2006, 84, S76-84.
41. Reynoso-Vallejo, H.; Chassler, D.; Witas, J.; Lundgren, L.M. Patterns of drug treatment entry by Latino male injection drug users from different national/geographical backgrounds. Eval. Program. Plann. 2008, 31, 92-101.